Quest PharmaTech Inc. (Quest) is a biotechnology company. The Company is engaged in the discovery, development and commercialization of pharmaceutical products. It is developing a portfolio of product candidates for the treatment of cancer by combining immunotherapeutic antibodies with chemotherapy, photodynamic therapy, radioimmunotherapy or immunoadjuvants. Quest is also developing a series of products for the treatment of cancer and dermatological conditions, based on its SonoLight Technology platform. Quest is developing monoclonal antibodies targeting certain tumor associated antigens that are presented in various cancers, including ovary, pancreas, lung, breast, prostate and stomach, and monoclonal antibody Oregovomab for the treatment of ovarian cancer. The Company�s product, SL017, is a topical formulation indicated for dermatology applications.